BiotechTube
Home/Orega Biotech/Armand Bensussan
AB

Armand Bensussan

Founder

Orega Biotech

Therapeutic Areas

Oncology

Orega Biotech Pipeline

DrugIndicationPhase
IPH5201 (anti-CD39 mAb)Non-Small Cell Lung Cancer (NSCLC)Phase 2
Undisclosed Antibody ProgramUndisclosedPre-clinical

Leadership Team at Orega Biotech

JB
Jeremy Bastid
CEO
GA
Gilles Alberici
Chairman
NB
Nathalie Bonnefoy
Founder & CSO
JE
Jean-François Eliaou
Founder
View full Orega Biotech profile